TY - JOUR
T1 - Hemangioblastic characteristics of fetal bone marrow-derived Flk1+CD31-CD34- cells
AU - Guo, Hong
AU - Fang, Baijun
AU - Liao, Lianming
AU - Zhao, Zhigang
AU - Liu, Jiewen
AU - Chen, Huishu
AU - Hsu, Steven H.
AU - Cui, Qi
AU - Zhao, Robort Chunhua
N1 - Funding Information:
We thank Catherine Verfaillie for critical reading of the manuscript, and Carla Mellough for comments. This work was supported by grants from “863 projects” of Ministry of Science and Technology of P.R. China (No. 2002AA205061); China Medical Board of New York, Inc (Grant No. 01-748); the National Natural Science Foundation of China (No. 30070284); National Key Project for Basic Research of China (No. 001CB5099); and Beijing Ministry of Science and Technology (No. 2002-489). RCH Zhao is a Cheung Kong Scholar in P.R. China.
PY - 2003/7/1
Y1 - 2003/7/1
N2 - Objective. To investigate whether Flk1+CD31-CD34- cells isolated from fetal bone marrow (BM) have characteristics of hemangioblasts, i.e., progenitors of endothelial and hematopoietic cells. Materials and Methods. Mononuclear cells from fetal BM were negatively sorted by CD45, GlyA, and CD34 micromagnetic beads, then cultured to form cell colonies. A single colony was harvested. Culture-expanded cells were seeded on ECM gel or semisolid media supplemented with endothelial and hematopoietic growth factors, respectively. Immunochemistry staining and RT-PCR were performed for cell characterization. Results. 99% of cells from the single colony maintained Flk1+ and CD31/CD34- during passaging. On ECM gel, Flk1+CD31-CD34- cells could grow into vascular structure that was positive for CD31 and vWF. There were round CD34+ cells around the vascular structure. When angiogenesis inhibitor suramin was added before tube formation, formation of vascular structure was blocked. Additionally, Flk1+CD31-CD34- cells cultured on hematopoietic condition could differentiate into hematopoietic cells which expressed GATA-1, 2, and γ, β globin gene. After being replated in methylcellulose medium, they formed typical erythroid colonies. Conclusions. Flk1+CD31-CD34- cells derived from fetal BM could differentiate into endothelial and hematopoietic cells. The results suggested that these Flk1+CD31-CD34- cells after embryo stage bear characteristics of hemangioblast and may have potential application for the hematopoietic and vascular diseases.
AB - Objective. To investigate whether Flk1+CD31-CD34- cells isolated from fetal bone marrow (BM) have characteristics of hemangioblasts, i.e., progenitors of endothelial and hematopoietic cells. Materials and Methods. Mononuclear cells from fetal BM were negatively sorted by CD45, GlyA, and CD34 micromagnetic beads, then cultured to form cell colonies. A single colony was harvested. Culture-expanded cells were seeded on ECM gel or semisolid media supplemented with endothelial and hematopoietic growth factors, respectively. Immunochemistry staining and RT-PCR were performed for cell characterization. Results. 99% of cells from the single colony maintained Flk1+ and CD31/CD34- during passaging. On ECM gel, Flk1+CD31-CD34- cells could grow into vascular structure that was positive for CD31 and vWF. There were round CD34+ cells around the vascular structure. When angiogenesis inhibitor suramin was added before tube formation, formation of vascular structure was blocked. Additionally, Flk1+CD31-CD34- cells cultured on hematopoietic condition could differentiate into hematopoietic cells which expressed GATA-1, 2, and γ, β globin gene. After being replated in methylcellulose medium, they formed typical erythroid colonies. Conclusions. Flk1+CD31-CD34- cells derived from fetal BM could differentiate into endothelial and hematopoietic cells. The results suggested that these Flk1+CD31-CD34- cells after embryo stage bear characteristics of hemangioblast and may have potential application for the hematopoietic and vascular diseases.
UR - http://www.scopus.com/inward/record.url?scp=0038722035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038722035&partnerID=8YFLogxK
U2 - 10.1016/S0301-472X(03)00087-0
DO - 10.1016/S0301-472X(03)00087-0
M3 - Article
C2 - 12842710
AN - SCOPUS:0038722035
VL - 31
SP - 650
EP - 658
JO - Experimental Hematology
JF - Experimental Hematology
SN - 0301-472X
IS - 7
ER -